Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art

키워드

참고문헌 (100)

1. Browne P, "Atlas of Multiple Sclerosis 2013 : a growing global problem with widespread inequity", Neurology, 83, pp.1022~1024 (2014)
2. Chwastiak LA, "Psychiatric issues in multiple sclerosis", Psychiatry Clin N Am, 30, pp.803~817 (2007)
3. José Sá M, "Psychological aspects of multiple sclerosis", Clin Neurol Neurosurg, 110, pp.868~877 (2008)
4. Adams K, "Why should I talk about emotion? Communication patterns associated with physician discussion of patient expressions of negative emotion in hospital admission encounters", Patient Educ Couns, 89, pp.44~50 (2012)
5. Boeije HR, "Encountering the downward phase : biographical work in people with multiple sclerosis living at home", Soc Sci Med, 55, pp.881~893 (2002)
6. Butler MA, "In search of a conceptualization of multiple sclerosis : a historical perspective", Neuropsychol Rev, 13, pp.93~112 (2003)
7. Cottrell SS, "Original Papers : the affective symptomatology of disseminated sclerosis : a study of 100 cases", J Neurol Psychopathol, 7, pp.1~30 (1926)
8. Ombredane A, "Les Troubles Mentaux de la Sclérose en Plaques" (1929), Presses Universitaires de France
9. Feinstein A, "The link between multiple sclerosis and depression", Nat Rev Neurol, 10, pp.507~517 (2014)
10. Minden SL, "Depression in multiple sclerosis", Gen Hosp Psychiatry, 9, pp.426~434 (1987)
11. Sullivan MFI, "Depression before and after diagnosis of multiple sclerosis", Mult Scler, 1, pp.104~108 (1995)
12. Possa MF, "The first year after diagnosis : psychological impact on people with multiple sclerosis", Psychol Health Med, 22, pp.1063~1071 (2017)
13. Noy S, "A new approach to affective symptoms in relapsing-remitting multiple sclerosis", Compr Psychiatry, 36, pp.390~395 (1995)
14. Pujol J, "Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis", Neurology, 49, pp.1105~1110 (1997)
15. Bakshi R, "Brain MRI lesions and atrophy are related to depression in multiple sclerosis", Neuroreport, 11, pp.1153~1158 (2000)
16. Gobbi C, "Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis", Mult Scler, 20, pp.192~201 (2014)
17. Gold SM, "Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling", Hum Brain Mapp, 35, pp.30~37 (2014)
18. Stuke H, "Cross-sectional and longitudinal relationships between depressive symptoms and brain atrophy in MS patients", Front Hum Neurosci, 10, pp.622~ (2016)
19. Kern S, "Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis", Psychoneuroendocrinology, 36, pp.1505~1512 (2011)
20. Fassbender K, "Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis", Arch Neurol, 55, pp.66~72 (1998)
21. Mohr DC, "Treatment of depression improves adherence to interferon beta1b therapy for multiple sclerosis", Arch Neurol, 54, pp.531~533 (1997)
22. Mohr DC, "Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis", Arch Neurol, 56, pp.1263~1265 (1999)
23. Patten SB, "Interferon beta1a and depression in secondary progressive MS : data from the SPECTRIMS Trial", Neurology, 59, pp.744~746 (2002)
24. Patti F, "Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a : 3-year results from the COGIMUS(COGnitive Impairment in MUltiple Sclerosis)study", Mult Scler, 17, pp.991~1001 (2011)
25. Mohr DC, "Depression, coping and level of neurological impairment in multiple sclerosis", Mult Scler, 3, pp.254~258 (1997)
26. Randolph JJ, "Neurovegetative symptoms in multiple sclerosis : relationship to depressed mood, fatigue, and physical disability", Arch Clin Neuropsychol, 15, pp.387~398 (2000)
27. Minden SL, "Evidence-based guideline : assessment and management of psychiatric disorders in individuals with MS : report of the Guideline Development Subcommittee of the American Academy of Neurology", Neurology, 82, pp.174~181 (2014)
28. Brenner P, "Fatigue and depression in multiple sclerosis : pharmacological and non-pharmacological interventions", Acta Neurol Scand, 134, pp.47~54 (2016)
29. Hind D, "Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis : a systematic review and meta-analysis", BMC Psychiatry, 14, pp.5~ (2014)
30. Rasmussen KG, "Electroconvulsive therapy in patients with multiple sclerosis", J ECT, 23, pp.179~180 (2007)
31. Tarrants M, "The impact of comorbid depression on adherence to therapy for multiple sclerosis", Mult Scler Int, 2011, pp.1~10 (2011)
32. Mullins LL, "Illness intrusiveness, uncertainty, and distress in individuals with multiple sclerosis", Rehabil Psychol, 46, pp.139~153 (2001)
33. Pompili M, "Suicide risk in multiple sclerosis : a systematic review of current literature", J Psychosom Res, 73, pp.411~417 (2012)
34. Feinstein A, "An examination of suicidal intent in patients with multiple sclerosis", Neurology, 59, pp.674~678 (2002)
35. Buhse M, "Assessment of caregiver burden in families of persons with multiple sclerosis", J Neurosci Nurs, 40, pp.25~31 (2008)
36. Marrie RA, "The incidence and prevalence of psychiatric disorders in multiple sclerosis : a systematic review", Mult Scler, 21, pp.305~317 (2015)
37. Korostil M, "Anxiety disorders and their clinical correlates in multiple sclerosis patients", Mult Scler, 13, pp.67~72 (2007)
38. Lin A, "Regional gray matter atrophy and neuropsychologcal problems in relapsing-remitting multiple sclerosis", Neural Regen Res, 8, pp.1958~1965 (2013)
39. Paparrigopoulos T, "The neuropsychiatry of multiple sclerosis : focus on disorders of mood, affect and behaviour", Int Rev Psychiatry, 22, pp.14~21 (2010)
40. Honarmand K, "Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients", Mult Scler, 15, pp.1518~1524 (2009)
41. Marrie RA, "Mental comorbidity and multiple sclerosis : validating administrative data to support population-based surveillance", BMC Neurol, 13, pp.16~ (2013)
42. Feinstein A, "Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study", Brit J Psychiatry, 161, pp.680~685 (1992)
43. Sidhom Y, "Bipolar disorder and multiple sclerosis : a case series", Behav Neurol, 2014, pp.1~4 (2014)
44. Pinkston JB, "Multiple sclerosis and behavior", Int Rev Neurobiol, 79, pp.323~339 (2007)
45. Kosmidis MH, "Psychotic features associated with multiple sclerosis", Int Rev Psychiatry, 22, pp.55~66 (2010)
46. Fricchione GL, "Psychotic disorders caused by a general medical condition, with delusions. Secondary ‘organic’ delusional syndromes", Psychiatr Clin North Am, 18, pp.363~378 (1995)
47. Gilberthorpe TG, "The spectrum of psychosis in multiple sclerosis : a clinical case series", Neuropsychiatr Dis Treat, 13, pp.303~318 (2017)
48. Sperner-Unterweger B, "Schizophrenia and psychoneuroimmunology", Curr Opin Psychiatry, 28, pp.201~206 (2015)
49. Goeb JL, "Acute delirium, delusion and depression during INF-beta-1a therapy for multiple sclerosis : a case report", Clin Neuropharmacol, 26, pp.5~7 (2003)
50. Harel Y, "Dysregulation of affect in multiple sclerosis : new phenomenological approach", Psychiatry Clin Neurosci, 61, pp.94~98 (2007)
51. Benedict RH, "Personality disorder in multiple sclerosis correlates with cognitive impairment", J Neuropsychiatry Clin Neurosci, 13, pp.70~76 (2001)
52. Feinstein A, "Neuropsychiatric syndromes associated with multiple sclerosis", J Neurol, 254(Suppl 2), pp.ii73~ii76 (2007)
53. Roy S, "Longitudinal personality change associated with cognitive decline in multiple sclerosis", Mult Scler (2018)
54. Sullivan LE, "The prevalence and impact of alcohol problems in major depression : a systematic review", Am J Med, 118, pp.330~341 (2005)
55. Lechtenberg R, "Multiple Sclerosis Fact Book" (1995), FA Davis
56. Chong MS, "Cannabis use in patients with multiple sclerosis", Mult Scler, 12, pp.646~651 (2006)
57. Feinstein A, "Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis", Arch Neurol, 54, pp.1116~1121 (1997)
58. Minden SL, "Affective disorders in multiple sclerosis", Arch Neurol, 47, pp.98~104 (1990)
59. Hübers A, "Pathological laughing and crying in amyotrophic lateral sclerosis is related to frontal cortex function", J Neurol, 263, pp.1788~1795 (2016)
60. Seliger GM, "Serotonin, fluoxetine, and pseudobulbar affect", Neurology, 39, pp.1400~1400 (1989)
61. Panitch HS, "Randomized controlled trial of dextromethorphan", quinidine for pseudobulbar affect in multiple sclerosis, 2006, pp.59, 780~787
62. Rabins PV, "Neurobehavioural Aspects of Multiple Sclerosis", pp.180~185 (1990), Oxford University Press
63. Calabrese P, "Neuropsychology of multiple sclerosis-- an overview", J Neurol, 253(Suppl 1), pp.i10~i15 (2006)
64. Reuter F, "Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis", J Neurol Neurosurg Psychiatry, 82, pp.1157~1159 (2010)
65. Savettieri G, "Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis", J Neurol, 251, pp.1208~1214 (2004)
66. Rossi F, "Relevance of brain lesion location to cognition in relapsing multiple sclerosis", PLoS One, 7, pp.e44826~ (2012)
67. Pinter D, "Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis", Neuroimage Clin, 7, pp.715~720 (2015)
68. Foong J, "Executive function in in multiple sclerosis. The role of frontal lobe pathology", Brain, 120(Pt1), pp.15~26 (1997)
69. Sperling RA, "Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis : a longitudinal study", Arch Neurol, 58, pp.115~121 (2001)
70. Hulst HE, "Cognitive impairment in MS : impact of white matter integrity, gray matter volume, and lesions", Neurology, 80, pp.1025~1032 (2013)
71. Calabrese M, "Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis", Arch Neurol, 66, pp.1144~1150 (2009)
72. Schoonheim MM, "Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis", Neurology, 84, pp.776~783 (2015)
73. Chiaravalloti ND, "Cognitive impairment in multiple sclerosis", Lancet Neurol, 7, pp.1139~1151 (2008)
74. Barak Y, "Effect of interferon-beta-1b on cognitive functions in multiple sclerosis", Eur Neurol, 47, pp.11~14 (2002)
75. Zéphir H, "One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis", Mult Scler, 11, pp.360~363 (2005)
76. Penner IK, "Evaluation of cognition and fatigue in multiple sclerosis: daily practice and future directions", Acta Neurol Scand, 134(Suppl 200), pp.19~23 (2016)
77. Patti F, "Prevalence and incidence of cognitive impairment in multiple sclerosis : a population-based survey in Catania, Sicily", J Neurol, 262, pp.923~930 (2015)
78. Lengenfelder J, "Processing speed interacts with working memory efficiency in multiple sclerosis", Arch Clin Neuropsychol, 21, pp.229~238 (2006)
79. Nebel K, "Activity of attention related structures in multiple sclerosis", Brain Res, 1151, pp.150~160 (2007)
80. Rao SM, "Memory dysfunction in multiple sclerosis : its relation to working memory, semantic encoding and implicit learning", Neuropsychology, 7, pp.364~374 (1993)
81. Thornton AE, "Memory in multiple sclerosis : contextual encoding deficits", J Int Neuropsychol Soc, 8, pp.395~409 (2002)
82. Grossman M, "Sentence comprehension in multiple sclerosis", Acta Neurol Scand, 92, pp.324~331 (1995)
83. Rao SM, "Neuropsychology of multiple sclerosis", Curr Opin Neurol, 8, pp.216~220 (1995)
84. Vleugels L, "Visuoperceptual impairment in MS patients : nature and possible neural origins", Mult Scler, 7, pp.389~401 (2001)
85. Rao SM, "Multiple Sclerosis: Clinical and Pathogenic Basis", pp.365~372 (1997), Chapman and Hall
86. Guidelines MSCP, "Fatigue and Multiple Sclerosis: Evidence-Based Management Strategies for Fatigue in Multiple Sclerosis" (1998), Paralyzed Veterans of America
87. Russo M, "Neural correlates of fatigue in multiple sclerosis: a combined neurophysiological and neuroimaging approach (R1)", Arch Ital Biol, 155, pp.142~151 (2017)
88. Finke C, "Altered basal ganglia functional connectivity in multiple sclerosis patients with fatigue", Mult Scler, 21, pp.925~934 (2015)
89. Krupp LB, "Fatigue in multiple sclerosis", Curr Neurol Neurosci Rep, 1, pp.294~298 (2001)
90. Karatepe AG, "Quality of life in patients with multiple sclerosis : the impact of depression, fatigue, and disability", Int J Rehabil Res, 34, pp.290~298 (2011)
91. Lobentanz IS, "Factors influencing quality of life in multiple sclerosis patients : disability, depressive mood, fatigue and sleep quality", Acta Neurol Scand, 110, pp.6~13 (2004)
92. Bakshi R, "Fatigue in multiple sclerosis and its relationship to depression and neurologic disability", Mult Scler, 6, pp.181~185 (2000)
93. Mohr DC, "Effects of treatment for depression on fatigue in multiple sclerosis", Psychosom Med, 65, pp.542~547 (2003)
94. Siegert RJ, "Depression in multiple sclerosis : a review", J Neurol Neurosurg Psychiatry, 76, pp.469~475 (2005)
95. Çelik DB, "Sexual dysfunction ın multiple sclerosis : gender differences", J Neurol Sci, 324, pp.17~20 (2013)
96. Guo ZN, "Multiple sclerosis and sexual dysfunction", Asian J Androl, 14, pp.530~535 (2012)
97. Zorzon M, "Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosis", Mult Scler, 9, pp.108~110 (2003)
98. Winder K, "Insular multiple sclerosis lesions are associated with erectile dysfunction", J Neurol, 265, pp.783~792 (2018)
99. Tan-Kristanto S, "Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis", Psychol Health Med, 20, pp.635~645 (2015)
100. Schwartz C, "Contribution of demographic, medical, and social support variables in predicting the mental health dimension of quality of life among people with multiple sclerosis", Health Soc Work, 30, pp.203~212 (2005)

관련 논문AI추천